{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:32:10Z","timestamp":1791595930278,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.colsurfb.2020.111203","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T11:45:46Z","timestamp":1592394346000},"page":"111203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies"],"prefix":"10.1016","volume":"194","author":[{"given":"Jafar Rahnama","family":"Yazdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Tafaghodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvan","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mashreghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Reza","family":"Nikpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nikoofal-Sahlabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshidkhan","family":"Chamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Alia","family":"Moosavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-6828","authenticated-orcid":false,"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2020.111203_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v4.i1.1","article-title":"Insulin therapies: current and future trends at dawn","volume":"4","author":"Yaturu","year":"2013","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nano.2013.07.011","article-title":"Biotinylated liposomes as potential carriers for the oral delivery of insulin","volume":"10","author":"Zhang","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/1520915041705929","article-title":"The physiological rationale for oral insulin administration","volume":"6","author":"Arbit","year":"2004","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-144-7-200604040-00005","article-title":"Improvements in diabetes processes of care and intermediate outcomes: United States, 1988\u20132002","volume":"144","author":"Saaddine","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2018.07.041","article-title":"Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus","author":"Wong","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.37285\/ijpsn.2010.3.3.3","article-title":"Novel Approaches for Oral Delivery of Insulin and Current Status of Oral Insulin Products","volume":"3","author":"Neelam","year":"2010","journal-title":"IJPSN"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0040","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.1016\/S2222-1808(14)60672-1","article-title":"Molecular identification of Leishmania species in Taybad district, Iran","volume":"4","author":"Ghodratollah","year":"2014","journal-title":"Asian Pacific J. Trop. Dis."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0045","series-title":"Nanostructures Oral Med.","first-page":"173","article-title":"Challenges in oral drug delivery: a nano-based strategy to overcome","author":"Viswanathan","year":"2017"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1556-276X-7-299","article-title":"Novel preparation of PLGA\/HP55 nanoparticles for oral insulin delivery","volume":"7","author":"Wu","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0060","first-page":"281","article-title":"Oral delivery of insulin: novel approaches","author":"Elsayed","year":"2012","journal-title":"Recent Adv. Nov. Drug Carr. Syst."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpb.2004.10.006","article-title":"Strategic approaches for overcoming peptide and protein instability within biodegradable nano-and microparticles","volume":"59","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jps.2600840604","article-title":"Absorption characteristics of chemically modified\u2010insulin derivatives with various fatty acids in the small and large intestine","volume":"84","author":"Asada","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0075","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0006-2952(87)90411-4","article-title":"Absorption of protein via the intestinal wall: a quantitative model","volume":"36","author":"Ziv","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00102-1","article-title":"W\/O\/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: biological activity after oral administration to normal and diabetic rats","volume":"169","author":"Silva-Cunha","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(01)00579-8","article-title":"Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat","volume":"216","author":"Kisel","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0090","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/jps.2600831020","article-title":"Enhancement of intestinal insulin absorption by bile salt\u2013fatty acid mixed micelles in dogs","volume":"83","author":"Scott-Moncrief","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jconrel.2004.10.032","article-title":"Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin\u2013microparticle conjugates in oral insulin delivery system","volume":"102","author":"Kim","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10989-005-9010-3","article-title":"Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers","volume":"12","author":"Sarmento","year":"2006","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(97)00237-8","article-title":"Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract","volume":"157","author":"Iwanaga","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0120","doi-asserted-by":"crossref","DOI":"10.1177\/117739280700200003","article-title":"Targeting receptors, transporters and site of absorption to improve oral drug delivery","volume":"2","author":"Hamman","year":"2007","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cocis.2010.12.005","article-title":"Fate of polymeric nanocarriers for oral drug delivery","volume":"16","author":"Plapied","year":"2011","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0135","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0140","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/17425247.2010.501792","article-title":"Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting","volume":"7","author":"Zaki","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0145","first-page":"1","article-title":"Oral nano-insulin therapy: current progress on nanoparticle-based devices for intestinal epithelium-targeted insulin delivery","volume":"4","author":"Ahmad","year":"2014","journal-title":"J. Nanomedic. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0150","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/mp2005388","article-title":"Folic acid functionalized nanoparticles for enhanced oral drug delivery","volume":"9","author":"Roger","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1556-276X-9-185","article-title":"Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity","volume":"9","author":"Zhang","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0160","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/bm0503165","article-title":"Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles","volume":"6","author":"Francis","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0165","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/anie.200800865","article-title":"Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs","volume":"48","author":"Petrus","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0170","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.addr.2013.01.002","article-title":"Targeted nanoparticles with novel non-peptidic ligands for oral delivery","volume":"65","author":"des Rieux","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bm401580k","article-title":"Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration","volume":"15","author":"Agrawal","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acs.molpharmaceut.5b00663","article-title":"Enhanced cytotoxicity of folic acid-targeted liposomes co-loaded with C6 ceramide and doxorubicin: in vitro evaluation on HeLa, A2780-ADR, and H69-AR cells","volume":"13","author":"Sriraman","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2015.08.048","article-title":"Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model","volume":"495","author":"Nikpoor","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0190","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.nano.2017.08.010","article-title":"Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: in vitro and in vivo studies","volume":"13","author":"Nikpoor","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0195","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1208\/s12249-014-0282-9","article-title":"Development of acid-resistant alginate\/trimethyl chitosan nanoparticles containing cationic \u03b2-cyclodextrin polymers for insulin oral delivery","volume":"16","author":"Mansourpour","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0200","first-page":"282","article-title":"Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids","volume":"22","author":"Hatamipour","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0205","first-page":"900","article-title":"Preparation of iodine-125-labeled insulin for radioimmunoassay: comparison of lactoperoxidase and chloramine-T iodination","volume":"19","author":"Wajchenberg","year":"1978","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","article-title":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment","volume":"264","author":"Wong","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0215","first-page":"5503","article-title":"Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40824-016-0083-1","article-title":"Liposomal delivery systems for intestinal lymphatic drug transport","volume":"20","author":"Ahn","year":"2016","journal-title":"Biomater. Res."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejpb.2012.04.001","article-title":"Oral administration of paclitaxel with pegylated poly (anhydride) nanoparticles: permeability and pharmacokinetic study","volume":"81","author":"Zabaleta","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/10611861003733953","article-title":"Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration","volume":"19","author":"Riviere","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0240","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/jp4105745","article-title":"Effect of PEGylation on drug entry into lipid bilayer","volume":"118","author":"Rissanen","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0245","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1093\/jn\/131.11.2819","article-title":"Folate receptor function is regulated in response to different cellular growth rates in cultured mammalian cells","volume":"131","author":"Doucette","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0250","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ab.2004.05.034","article-title":"Pteroyl-\u03b3-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes","volume":"332","author":"Zhang","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0255","first-page":"333","article-title":"Drug delivery to the lymphatic system","volume":"14","author":"Porter","year":"1997","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.colsurfb.2020.111203_bib0260","first-page":"1155","article-title":"Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation","volume":"6","author":"Niu","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.colsurfb.2020.111203_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2017.11.007","article-title":"Biomimetic thiamine-and niacin-decorated liposomes for enhanced oral delivery of insulin","volume":"8","author":"He","year":"2018","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520305592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520305592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:53:47Z","timestamp":1760525627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776520305592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":53,"alternative-id":["S0927776520305592"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111203","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111203"}}